Shelter Mutual Insurance Co held its stake in shares of Core Laboratories N.V. (NYSE:CLB) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,900 shares of the oil and gas company’s stock at the end of the second quarter. Shelter Mutual Insurance Co owned approximately 0.09% of Core Laboratories N.V. worth $4,142,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in CLB. Genesee Valley Trust Co. increased its stake in shares of Core Laboratories N.V. by 0.3% in the first quarter. Genesee Valley Trust Co. now owns 5,538 shares of the oil and gas company’s stock valued at $639,000 after buying an additional 16 shares during the last quarter. Stephens Inc. AR increased its stake in shares of Core Laboratories N.V. by 1.0% in the first quarter. Stephens Inc. AR now owns 3,046 shares of the oil and gas company’s stock valued at $352,000 after buying an additional 31 shares during the last quarter. Creative Planning increased its stake in shares of Core Laboratories N.V. by 1.9% in the first quarter. Creative Planning now owns 1,730 shares of the oil and gas company’s stock valued at $200,000 after buying an additional 33 shares during the last quarter. Callahan Advisors LLC increased its stake in shares of Core Laboratories N.V. by 2.5% in the second quarter. Callahan Advisors LLC now owns 2,075 shares of the oil and gas company’s stock valued at $210,000 after buying an additional 50 shares during the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its stake in shares of Core Laboratories N.V. by 0.9% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 6,667 shares of the oil and gas company’s stock valued at $770,000 after buying an additional 59 shares during the last quarter.

Core Laboratories N.V. (NYSE:CLB) opened at 87.78 on Tuesday. Core Laboratories N.V. has a 12-month low of $87.22 and a 12-month high of $125.83. The company has a market cap of $3.87 billion, a P/E ratio of 53.85 and a beta of 1.60. The firm has a 50-day moving average price of $98.61 and a 200-day moving average price of $106.75.

Core Laboratories N.V. (NYSE:CLB) last released its earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The firm had revenue of $163.90 million during the quarter, compared to analyst estimates of $168.23 million. During the same period last year, the business posted $0.35 earnings per share. Core Laboratories N.V.’s revenue was up 10.7% compared to the same quarter last year. On average, equities research analysts forecast that Core Laboratories N.V. will post $2.09 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, August 14th. Shareholders of record on Monday, July 17th were paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend was Thursday, July 13th. Core Laboratories N.V.’s dividend payout ratio is presently 134.15%.

ILLEGAL ACTIVITY NOTICE: “Shelter Mutual Insurance Co Continues to Hold Position in Core Laboratories N.V. (CLB)” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.watchlistnews.com/shelter-mutual-insurance-co-continues-to-hold-position-in-core-laboratories-n-v-clb/1529751.html.

Several analysts have weighed in on the company. Royal Bank Of Canada set a $145.00 price objective on Core Laboratories N.V. and gave the company a “buy” rating in a research report on Saturday, June 17th. BidaskClub upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Tuesday, June 13th. Citigroup Inc. decreased their target price on Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating for the company in a report on Wednesday, July 26th. Zacks Investment Research upgraded Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $116.00 target price for the company in a report on Monday, June 12th. Finally, ValuEngine downgraded Core Laboratories N.V. from a “hold” rating to a “sell” rating in a report on Tuesday, June 6th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $116.75.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.